MedPath
HSA Approval

KETOROLAC TROMETHAMINE INJECTION 30 mg/ml

SIN11340P

KETOROLAC TROMETHAMINE INJECTION 30 mg/ml

KETOROLAC TROMETHAMINE INJECTION 30 mg/ml

June 16, 2000

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

M01AB15

ketorolac

Manufacturer Information

PFIZER PRIVATE LIMITED

HOSPIRA INC

Active Ingredients

KETOROLAC TROMETHAMINE

30 mg/ml

Ketorolac

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KETOROLAC TROMETHAMINE INJECTION 30 mg/ml - HSA Approval | MedPath